Published in PLoS One on May 04, 2015
Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study. Lipids Health Dis (2016) 0.75
Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer. J Int Med Res (2016) 0.75
eDGAR: a database of Disease-Gene Associations with annotated Relationships among genes. BMC Genomics (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract (2012) 4.11
Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab (2011) 2.47
Homocysteine and vascular disease. Nat Med (1996) 2.44
Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab (2003) 2.27
Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients. Am J Hypertens (2014) 2.22
Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab (2006) 2.17
Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol (2007) 1.88
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol (2009) 1.77
Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab (2010) 1.74
Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol (2004) 1.68
Subclinical thyroid disease. Am J Med (2010) 1.60
Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood (2002) 1.59
Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis (2001) 1.43
Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab (2006) 1.36
Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med (2006) 1.32
Thyroid hormone and atherosclerosis. Vascul Pharmacol (2009) 1.20
Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol (2002) 1.14
Homocysteine upregulates resistin production from adipocytes in vivo and in vitro. Diabetes (2008) 1.13
Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem (2013) 1.08
The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am (2012) 1.07
Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod (2003) 1.06
Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci (Lond) (2003) 1.04
Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol (2004) 1.04
Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can J Physiol Pharmacol (2007) 1.04
Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol (2013) 1.02
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord (2006) 1.02
Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol (2008) 1.00
Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression. J Cell Physiol (2011) 0.99
Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis (2008) 0.98
Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. Springerplus (2013) 0.92
Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells. Cell Biol Int (2012) 0.89
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes. Chin Med J (Engl) (2004) 0.87
Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis (2005) 0.86
Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia. J Hum Hypertens (2014) 0.84
A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Med Hypotheses (2002) 0.83
The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. J Obstet Gynaecol Res (2008) 0.83
Homocysteine and atherothrombosis. Lipids (2001) 0.78
Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats. Arch Med Res (2002) 0.78
Effects of levothyroxine treatment on insulin sensitivity, endothelial function and risk factors of atherosclerosis in hypothyroid women. Ann Endocrinol (Paris) (2014) 0.77
Hypothyroidism associated with acromegaly and insulin-resistant diabetes mellitus in a Samoyed. Aust Vet J (2014) 0.76